Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 400 | 749 | 1,014 | 1,481 | 1,398 |
| Gross Profit | 400 | 749 | 1,014 | 1,481 | 1,398 |
| Operating Expenses | 22,180 | 20,421 | 21,603 | 28,067 | 29,414 |
| Operating Income | -21,780 | -19,672 | -20,589 | -26,586 | -28,016 |
| Other Income | 2,968 | 138 | 361 | 530 | 699 |
| Pre-tax Income | -18,812 | -19,534 | -20,228 | -26,056 | -27,317 |
| Net Income Continuous | -18,812 | -19,534 | -20,228 | -26,056 | -27,317 |
| Net Income | $-18,812 | $-19,534 | $-20,228 | $-26,056 | $-27,317 |
| EPS Basic Total Ops | -11.80 | -14.00 | -14.60 | -18.80 | -20.00 |
| EPS Basic Continuous Ops | -11.72 | -14.06 | -14.62 | -19.08 | -19.91 |
| EPS Diluted Total Ops | -11.80 | -14.00 | -14.60 | -18.80 | -20.00 |
| EPS Diluted Continuous Ops | -11.72 | -14.06 | -14.62 | -19.08 | -19.91 |
| EBITDA(a) | $-21,192 | $-19,059 | $-19,963 | $-25,933 | $-27,319 |